From: Media reporting of tenofovir trials in Cambodia and Cameroon
Study | Total | Investigator | Potential participant | Representatives of participant groups | Activist group | Others |
---|---|---|---|---|---|---|
Cambodia | 24 | 3 (12.5%) | 1 (4.1%) | 1 (4.1%) | 3 (12.5%) | 3 (12.5%) NIAID representative; Cambodian AIDS authority; Bio-consultant |
Cameroon | 13 | 4 (30.8%) | 0 | 1 (7.7%) | 6 (46.2%) | 1 (7.7%) Local physician |